Literature DB >> 29079597

Single-molecule DNA sequencing of acute myeloid leukemia and myelodysplastic syndromes with multiple TP53 alterations.

Laurence Lodé1,2, Adam Ameur3, Thibault Coste1,4, Audrey Ménard2, Steven Richebourg2,5, Jean-Baptiste Gaillard4, Yannick Le Bris2, Marie-Christine Béné2, Thierry Lavabre-Bertrand4, Thierry Soussi6,7,8.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 29079597      PMCID： PMC5777207          DOI： 10.3324/haematol.2017.176719

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  12 in total

1.  TP53 mutations in low-risk myelodysplastic syndromes with del(5q) predict disease progression.

Authors:  Martin Jädersten; Leonie Saft; Alexander Smith; Austin Kulasekararaj; Sabine Pomplun; Gudrun Göhring; Anette Hedlund; Robert Hast; Brigitte Schlegelberger; Anna Porwit; Eva Hellström-Lindberg; Ghulam J Mufti
Journal:  J Clin Oncol       Date:  2011-04-25       Impact factor: 44.544

2.  Genomic Classification and Prognosis in Acute Myeloid Leukemia.

Authors:  Elli Papaemmanuil; Moritz Gerstung; Hartmut Döhner; Peter J Campbell; Lars Bullinger; Verena I Gaidzik; Peter Paschka; Nicola D Roberts; Nicola E Potter; Michael Heuser; Felicitas Thol; Niccolo Bolli; Gunes Gundem; Peter Van Loo; Inigo Martincorena; Peter Ganly; Laura Mudie; Stuart McLaren; Sarah O'Meara; Keiran Raine; David R Jones; Jon W Teague; Adam P Butler; Mel F Greaves; Arnold Ganser; Konstanze Döhner; Richard F Schlenk
Journal:  N Engl J Med       Date:  2016-06-09       Impact factor: 91.245

Review 3.  Recommended Guidelines for Validation, Quality Control, and Reporting of TP53 Variants in Clinical Practice.

Authors:  Bernard Leroy; Mandy L Ballinger; Fanny Baran-Marszak; Gareth L Bond; Antony Braithwaite; Nicole Concin; Lawrence A Donehower; Wafik S El-Deiry; Pierre Fenaux; Gianluca Gaidano; Anita Langerød; Eva Hellstrom-Lindberg; Richard Iggo; Jacqueline Lehmann-Che; Phuong L Mai; David Malkin; Ute M Moll; Jeffrey N Myers; Kim E Nichols; Sarka Pospisilova; Patricia Ashton-Prolla; Davide Rossi; Sharon A Savage; Louise C Strong; Patricia N Tonin; Robert Zeillinger; Thorsten Zenz; Joseph F Fraumeni; Peter E M Taschner; Pierre Hainaut; Thierry Soussi
Journal:  Cancer Res       Date:  2017-03-15       Impact factor: 12.701

4.  Prognostic Mutations in Myelodysplastic Syndrome after Stem-Cell Transplantation.

Authors:  R Coleman Lindsley; Wael Saber; Brenton G Mar; Robert Redd; Tao Wang; Michael D Haagenson; Peter V Grauman; Zhen-Huan Hu; Stephen R Spellman; Stephanie J Lee; Michael R Verneris; Katharine Hsu; Katharina Fleischhauer; Corey Cutler; Joseph H Antin; Donna Neuberg; Benjamin L Ebert
Journal:  N Engl J Med       Date:  2017-02-09       Impact factor: 91.245

Review 5.  Intra-tumour heterogeneity: a looking glass for cancer?

Authors:  Andriy Marusyk; Vanessa Almendro; Kornelia Polyak
Journal:  Nat Rev Cancer       Date:  2012-04-19       Impact factor: 60.716

6.  Prevalence, clonal dynamics and clinical impact of TP53 mutations in patients with myelodysplastic syndrome with isolated deletion (5q) treated with lenalidomide: results from a prospective multicenter study of the german MDS study group (GMDS).

Authors:  M Mossner; J-C Jann; D Nowak; U Platzbecker; A Giagounidis; K Götze; A Letsch; D Haase; K Shirneshan; F Braulke; R F Schlenk; T Haferlach; P Schafhausen; G Bug; M Lübbert; A Ganser; G Büsche; E Schuler; V Nowak; J Pressler; J Obländer; S Fey; N Müller; E Lauinger-Lörsch; G Metzgeroth; C Weiß; W-K Hofmann; U Germing; F Nolte
Journal:  Leukemia       Date:  2016-05-02       Impact factor: 11.528

Review 7.  TP53 mutations in human cancer: database reassessment and prospects for the next decade.

Authors:  Bernard Leroy; Martha Anderson; Thierry Soussi
Journal:  Hum Mutat       Date:  2014-06       Impact factor: 4.878

8.  Correlation analysis of p53 protein isoforms with NPM1/FLT3 mutations and therapy response in acute myeloid leukemia.

Authors:  N Ånensen; S M Hjelle; W Van Belle; I Haaland; E Silden; J-C Bourdon; R Hovland; K Taskén; S Knappskog; P E Lønning; Ø Bruserud; B T Gjertsen
Journal:  Oncogene       Date:  2011-08-22       Impact factor: 9.867

9.  Clonal evolution in myelodysplastic syndromes.

Authors:  Pedro da Silva-Coelho; Leonie I Kroeze; Kenichi Yoshida; Theresia N Koorenhof-Scheele; Ruth Knops; Louis T van de Locht; Aniek O de Graaf; Marion Massop; Sarah Sandmann; Martin Dugas; Marian J Stevens-Kroef; Jaroslav Cermak; Yuichi Shiraishi; Kenichi Chiba; Hiroko Tanaka; Satoru Miyano; Theo de Witte; Nicole M A Blijlevens; Petra Muus; Gerwin Huls; Bert A van der Reijden; Seishi Ogawa; Joop H Jansen
Journal:  Nat Commun       Date:  2017-04-21       Impact factor: 14.919

10.  Diagnosis and treatment of primary myelodysplastic syndromes in adults: recommendations from the European LeukemiaNet.

Authors:  Luca Malcovati; Eva Hellström-Lindberg; David Bowen; Lionel Adès; Jaroslav Cermak; Consuelo Del Cañizo; Matteo G Della Porta; Pierre Fenaux; Norbert Gattermann; Ulrich Germing; Joop H Jansen; Moshe Mittelman; Ghulam Mufti; Uwe Platzbecker; Guillermo F Sanz; Dominik Selleslag; Mette Skov-Holm; Reinhard Stauder; Argiris Symeonidis; Arjan A van de Loosdrecht; Theo de Witte; Mario Cazzola
Journal:  Blood       Date:  2013-08-26       Impact factor: 22.113
View more
  9 in total

1.  Fam83F induces p53 stabilisation and promotes its activity.

Authors:  Mohammed Salama; Diego Benitez-Riquelme; Seham Elabd; Leonel Munoz; Ping Zhang; Matthias Glanemann; Maria Caterina Mione; Robert Goldin; Thierry Soussi; Gary Davidson; Christine Blattner
Journal:  Cell Death Differ       Date:  2019-01-28       Impact factor: 15.828

Review 2.  Single molecule real-time (SMRT) sequencing comes of age: applications and utilities for medical diagnostics.

Authors:  Simon Ardui; Adam Ameur; Joris R Vermeesch; Matthew S Hestand
Journal:  Nucleic Acids Res       Date:  2018-03-16       Impact factor: 16.971

3.  Long-read sequencing across the C9orf72 'GGGGCC' repeat expansion: implications for clinical use and genetic discovery efforts in human disease.

Authors:  Mark T W Ebbert; Stefan L Farrugia; Jonathon P Sens; Karen Jansen-West; Tania F Gendron; Mercedes Prudencio; Ian J McLaughlin; Brett Bowman; Matthew Seetin; Mariely DeJesus-Hernandez; Jazmyne Jackson; Patricia H Brown; Dennis W Dickson; Marka van Blitterswijk; Rosa Rademakers; Leonard Petrucelli; John D Fryer
Journal:  Mol Neurodegener       Date:  2018-08-21       Impact factor: 14.195

Review 4.  Evolutionary trajectory of leukemic clones and its clinical implications.

Authors:  Amos Tuval; Liran I Shlush
Journal:  Haematologica       Date:  2019-04-19       Impact factor: 9.941

Review 5.  Long-Read Sequencing Emerging in Medical Genetics.

Authors:  Tuomo Mantere; Simone Kersten; Alexander Hoischen
Journal:  Front Genet       Date:  2019-05-07       Impact factor: 4.599

6.  Detailed analysis of HTT repeat elements in human blood using targeted amplification-free long-read sequencing.

Authors:  Ida Höijer; Yu-Chih Tsai; Tyson A Clark; Paul Kotturi; Niklas Dahl; Eva-Lena Stattin; Marie-Louise Bondeson; Lars Feuk; Ulf Gyllensten; Adam Ameur
Journal:  Hum Mutat       Date:  2018-07-12       Impact factor: 4.878

Review 7.  Long reads: their purpose and place.

Authors:  Martin O Pollard; Deepti Gurdasani; Alexander J Mentzer; Tarryn Porter; Manjinder S Sandhu
Journal:  Hum Mol Genet       Date:  2018-08-01       Impact factor: 6.150

Review 8.  TP53 in Myelodysplastic Syndromes: Recent Biological and Clinical Findings.

Authors:  Cosimo Cumbo; Giuseppina Tota; Luisa Anelli; Antonella Zagaria; Giorgina Specchia; Francesco Albano
Journal:  Int J Mol Sci       Date:  2020-05-13       Impact factor: 5.923

9.  Xdrop: Targeted sequencing of long DNA molecules from low input samples using droplet sorting.

Authors:  Esben B Madsen; Ida Höijer; Thomas Kvist; Adam Ameur; Marie J Mikkelsen
Journal:  Hum Mutat       Date:  2020-06-29       Impact factor: 4.878
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.